These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 22996693)

  • 1. CXCR1/2 inhibition enhances pancreatic islet survival after transplantation.
    Citro A; Cantarelli E; Maffi P; Nano R; Melzi R; Mercalli A; Dugnani E; Sordi V; Magistretti P; Daffonchio L; Ruffini PA; Allegretti M; Secchi A; Bonifacio E; Piemonti L
    J Clin Invest; 2012 Oct; 122(10):3647-51. PubMed ID: 22996693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Inflammatory Strategies in Intrahepatic Islet Transplantation: A Comparative Study in Preclinical Models.
    Citro A; Cantarelli E; Pellegrini S; Dugnani E; Piemonti L
    Transplantation; 2018 Feb; 102(2):240-248. PubMed ID: 28902069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reparixin, a CXCR1/2 inhibitor in islet allotransplantation.
    Pawlick RL; Wink J; Pepper AR; Bruni A; Abualhassen N; Rafiei Y; Gala-Lopez B; Bral M; Shapiro AM
    Islets; 2016 Sep; 8(5):115-24. PubMed ID: 27328412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HMGB1-Mediated Early Loss of Transplanted Islets Is Prevented by Anti-IL-6R Antibody in Mice.
    Itoh T; Nitta T; Nishinakamura H; Kojima D; Mera T; Ono J; Kodama S; Yasunami Y
    Pancreas; 2015 Jan; 44(1):166-71. PubMed ID: 25058889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXCR1/2 inhibition blocks and reverses type 1 diabetes in mice.
    Citro A; Valle A; Cantarelli E; Mercalli A; Pellegrini S; Liberati D; Daffonchio L; Kastsiuchenka O; Ruffini PA; Battaglia M; Allegretti M; Piemonti L
    Diabetes; 2015 Apr; 64(4):1329-40. PubMed ID: 25315007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting CXCR1/2 Does Not Improve Insulin Secretion After Pancreatic Islet Transplantation: A Phase 3, Double-Blind, Randomized, Placebo-Controlled Trial in Type 1 Diabetes.
    Maffi P; Lundgren T; Tufveson G; Rafael E; Shaw JAM; Liew A; Saudek F; Witkowski P; Golab K; Bertuzzi F; Gustafsson B; Daffonchio L; Ruffini PA; Piemonti L;
    Diabetes Care; 2020 Apr; 43(4):710-718. PubMed ID: 32019854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXCL1-CXCR1/2 signaling is induced in human temporal lobe epilepsy and contributes to seizures in a murine model of acquired epilepsy.
    Di Sapia R; Zimmer TS; Kebede V; Balosso S; Ravizza T; Sorrentino D; Castillo MAM; Porcu L; Cattani F; Ruocco A; Aronica E; Allegretti M; Brandolini L; Vezzani A
    Neurobiol Dis; 2021 Oct; 158():105468. PubMed ID: 34358616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-mobility group box 1 is involved in the initial events of early loss of transplanted islets in mice.
    Matsuoka N; Itoh T; Watarai H; Sekine-Kondo E; Nagata N; Okamoto K; Mera T; Yamamoto H; Yamada S; Maruyama I; Taniguchi M; Yasunami Y
    J Clin Invest; 2010 Mar; 120(3):735-43. PubMed ID: 20124731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting CXCR1/2 in the first multicenter, double-blinded, randomized trial in autologous islet transplant recipients.
    Witkowski P; Wijkstrom M; Bachul PJ; Morgan KA; Levy M; Onaca N; Chaidarun SS; Gardner T; Shapiro AMJ; Posselt A; Ahmad SA; Daffonchio L; Ruffini PA; Bellin MD
    Am J Transplant; 2021 Nov; 21(11):3714-3724. PubMed ID: 34033222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of early loss of transplanted islets in the liver of mice by adenosine.
    Nitta T; Itoh T; Matsuoka N; Mera T; Kojima D; Nakano M; Yamashita Y; Yasunami Y
    Transplantation; 2009 Jul; 88(1):49-56. PubMed ID: 19584680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Operational immune tolerance towards transplanted allogeneic pancreatic islets in mice and a non-human primate.
    Abdulreda MH; Berman DM; Shishido A; Martin C; Hossameldin M; Tschiggfrie A; Hernandez LF; Hernandez A; Ricordi C; Parel JM; Jankowska-Gan E; Burlingham WJ; Arrieta-Quintero EA; Perez VL; Kenyon NS; Berggren PO
    Diabetologia; 2019 May; 62(5):811-821. PubMed ID: 30701283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The chemokine receptors CXCR1/CXCR2 modulate antigen-induced arthritis by regulating adhesion of neutrophils to the synovial microvasculature.
    Coelho FM; Pinho V; Amaral FA; Sachs D; Costa VV; Rodrigues DH; Vieira AT; Silva TA; Souza DG; Bertini R; Teixeira AL; Teixeira MM
    Arthritis Rheum; 2008 Aug; 58(8):2329-37. PubMed ID: 18668539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engraftment Site and Effectiveness of the Pan-Caspase Inhibitor F573 to Improve Engraftment in Mouse and Human Islet Transplantation in Mice.
    Pepper AR; Bruni A; Pawlick R; Wink J; Rafiei Y; Gala-Lopez B; Bral M; Abualhassan N; Kin T; Shapiro AMJ
    Transplantation; 2017 Oct; 101(10):2321-2329. PubMed ID: 28072753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophil chemotaxis caused by chronic obstructive pulmonary disease alveolar macrophages: the role of CXCL8 and the receptors CXCR1/CXCR2.
    Kaur M; Singh D
    J Pharmacol Exp Ther; 2013 Oct; 347(1):173-80. PubMed ID: 23912333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-TCR mAb induces peripheral tolerance to alloantigens and delays islet allograft rejection in autoimmune diabetic NOD mice.
    Deng R; Khattar M; Xie A; Schroder PM; He X; Chen W; Stepkowski SM
    Transplantation; 2014 Jun; 97(12):1216-24. PubMed ID: 24854475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-melanocyte stimulating hormone preserves islet graft survival through down-regulation of Toll-like receptors.
    Jung EJ; Kim SC; Jeong SH; Lee JY; Han DJ
    Transplant Proc; 2012 May; 44(4):1086-90. PubMed ID: 22564632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The chemokine receptors CXCR1 and CXCR2 couple to distinct G protein-coupled receptor kinases to mediate and regulate leukocyte functions.
    Raghuwanshi SK; Su Y; Singh V; Haynes K; Richmond A; Richardson RM
    J Immunol; 2012 Sep; 189(6):2824-32. PubMed ID: 22869904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment with DF 2162, a non-competitive allosteric inhibitor of CXCR1/2, diminishes neutrophil influx and inflammatory hypernociception in mice.
    Cunha TM; Barsante MM; Guerrero AT; Verri WA; Ferreira SH; Coelho FM; Bertini R; Di Giacinto C; Allegretti M; Cunha FQ; Teixeira MM
    Br J Pharmacol; 2008 May; 154(2):460-70. PubMed ID: 18362895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Subcutaneous Site of Islet Transplantation Superior to the Liver.
    Yasunami Y; Nakafusa Y; Nitta N; Nakamura M; Goto M; Ono J; Taniguchi M
    Transplantation; 2018 Jun; 102(6):945-952. PubMed ID: 29521877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DF2755A, a novel non-competitive allosteric inhibitor of CXCR1/2, reduces inflammatory and post-operative pain.
    Lopes AH; Brandolini L; Aramini A; Bianchini G; Silva RL; Zaperlon AC; Verri WA; Alves-Filho JC; Cunha FQ; Teixeira MM; Allegretti M; Cunha TM
    Pharmacol Res; 2016 Jan; 103():69-79. PubMed ID: 26592483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.